A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2003

Conditions
Postherpetic NeuralgiaDiabetic NeuropathyComplex Regional Pain SyndromeCarpal Tunnel SyndromeHIV NeuropathyIdiopathic Sensory NeuropathyPeripheral Neuropathy
Interventions
DRUG

Placebo Capsules + Placebo Patch

Patients participated in a 5-week treatment period. Eligible patients were randomized into one of four treatment groups: placebo capsules + placebo patch (Placebo Group), placebo capsules + Lidoderm patch (Lidocaine Group), Gabapentin capsules 1800 mg/day + placebo patch (Gabapentin Group), or Gabapentin capsules 1800 mg/day + Lidoderm patch (Combination Group).

DRUG

Placebo capsules + Lidoderm®

Patients participated in a 5-week treatment period. Eligible patients were randomized into one of four treatment groups: placebo capsules + placebo patch (Placebo Group), placebo capsules + Lidoderm patch (Lidocaine Group), Gabapentin capsules 1800 mg/day + placebo patch (Gabapentin Group), or Gabapentin capsules 1800 mg/day + Lidoderm patch (Combination Group).

DRUG

Gabapentin + Placebo

Patients participated in a 5-week treatment period. Eligible patients were randomized into one of four treatment groups: placebo capsules + placebo patch (Placebo Group), placebo capsules + Lidoderm patch (Lidocaine Group), Gabapentin capsules 1800 mg/day + placebo patch (Gabapentin Group), or Gabapentin capsules 1800 mg/day + Lidoderm patch (Combination Group).

DRUG

Gabapentin + Lidoderm®

Patients participated in a 5-week treatment period. Eligible patients were randomized into one of four treatment groups: placebo capsules + placebo patch (Placebo Group), placebo capsules + Lidoderm patch (Lidocaine Group), Gabapentin capsules 1800 mg/day + placebo patch (Gabapentin Group), or Gabapentin capsules 1800 mg/day + Lidoderm patch (Combination Group).

DRUG

Gabapentin 300 mg capsules 1800 mg/day + placebo patch

Gabapentin 300 mg capsules 1800 mg/day + placebo patch

DRUG

Gabapentin 1800 mg/day + Lidoderm patch

Trial Locations (7)

Unknown

Birmingham

Hueytown

Phoenix

Pembroke Pines

New York

Rochester

Altoona

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY